Armand Keating
Directeur Technique/Scientifique/R&D chez ROQUEFORT THERAPEUTICS PLC
Profil
Armand Keating is the founder of panCELLa, Inc. founded in 2015.
He is currently a Director at Tissue Regeneration Therapeutics, Inc. and Pancella Therapeutics, Inc. He is also the Chief Medical Officer at Roquefort Therapeutics Plc since 2022.
Dr. Keating's former positions include being a Professor at the University of Toronto, President of the American Society of Hematology, President of the American Society for Blood & Marrow Transplantation, and Chief Medical Services at Princess Margaret Hospital.
Postes actifs de Armand Keating
Sociétés | Poste | Début |
---|---|---|
ROQUEFORT THERAPEUTICS PLC | Directeur Technique/Scientifique/R&D | 16/09/2022 |
Tissue Regeneration Therapeutics, Inc.
Tissue Regeneration Therapeutics, Inc. BiotechnologyHealth Technology Tissue Regeneration Therapeutics, Inc. operates as a biotechnology company. It develops osteoscaf, a biodegradable and osteoconductive scaffold for use in healing tissue defects. The company is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | - |
Pancella Therapeutics, Inc.
Pancella Therapeutics, Inc. BiotechnologyHealth Technology Pancella Therapeutics, Inc. develops novel therapies for geno dermatoses. The company is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | - |
panCELLa, Inc.
panCELLa, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pluristyx, Inc., panCELLa, Inc. is a privately held early-stage biotechnology firm based in Toronto, CA. panCELLa was acquired by Pluristyx, Inc. on October 06, 2022. panCELLa has secured partnerships with several biotechnology partners to enhance its patent position and provide expanded access to its exclusive failsafe™ and cloaked cells™/iact cells. The Canadian company continues its internal R & D efforts to develop additional novel uses of its platform technologies in areas such as bio-production, cancer vaccination, and tolerization. The private company was founded in 2015 by Armand Keating and Andras Nagy, and has created platforms that allow for the development of safe, universal, cost-effective, “ off-the-shelf ” therapeutic cell products for medicine. | Fondateur | 01/01/2015 |
Anciens postes connus de Armand Keating
Sociétés | Poste | Fin |
---|---|---|
Princess Margaret Hospital | Directeur Technique/Scientifique/R&D | - |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | President | - |
American Society for Blood & Marrow Transplantation | President | - |
University of Toronto | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ROQUEFORT THERAPEUTICS PLC | Health Technology |
Entreprise privées | 6 |
---|---|
Tissue Regeneration Therapeutics, Inc.
Tissue Regeneration Therapeutics, Inc. BiotechnologyHealth Technology Tissue Regeneration Therapeutics, Inc. operates as a biotechnology company. It develops osteoscaf, a biodegradable and osteoconductive scaffold for use in healing tissue defects. The company is headquartered in Toronto, Canada. | Health Technology |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Commercial Services |
American Society for Blood & Marrow Transplantation | |
Princess Margaret Hospital | |
Pancella Therapeutics, Inc.
Pancella Therapeutics, Inc. BiotechnologyHealth Technology Pancella Therapeutics, Inc. develops novel therapies for geno dermatoses. The company is headquartered in Toronto, Canada. | Health Technology |
panCELLa, Inc.
panCELLa, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Pluristyx, Inc., panCELLa, Inc. is a privately held early-stage biotechnology firm based in Toronto, CA. panCELLa was acquired by Pluristyx, Inc. on October 06, 2022. panCELLa has secured partnerships with several biotechnology partners to enhance its patent position and provide expanded access to its exclusive failsafe™ and cloaked cells™/iact cells. The Canadian company continues its internal R & D efforts to develop additional novel uses of its platform technologies in areas such as bio-production, cancer vaccination, and tolerization. The private company was founded in 2015 by Armand Keating and Andras Nagy, and has created platforms that allow for the development of safe, universal, cost-effective, “ off-the-shelf ” therapeutic cell products for medicine. | Commercial Services |